European Myeloma Network

Academic/HospitalWebsite ↗

Also known as: EMN Research Italy | EMN Research Italy Impresa Sociale Srl | European Myeloma Network | European Myeloma Network B.V. | Stichting European Myeloma Network

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Sep 1, 2006

Last known activity

Oct 31, 2025

Timeline

2000s

Jan 1, 2005
European Myeloma Network— Founded

Drugs by trial phase (23 distinct, 22 trials)

Phase 3 (17 own, 0 via acquisition)

Phase 2 (6 own, 0 via acquisition)

Indications

Studied for

Recent trials (26)

NCT07107529Lead sponsorPhase 2Oct 31, 2025
NCT06932562Lead sponsorPhase 3Oct 31, 2025
NCT06649695Lead sponsorPhase 2Mar 31, 2025
NCT06183489Lead sponsorPhase 2Jan 31, 2024
NCT06189833Lead sponsorPhase 2Nov 23, 2023
NCT05257083Lead sponsorPhase 3Dec 31, 2022
NCT05243797Lead sponsorPhase 3Apr 12, 2022
NCT04965155Lead sponsorPhase 2Dec 2, 2021
NCT05028348Lead sponsorPhase 3Oct 31, 2021
NCT04564703CollaboratorPhase 2Dec 31, 2020
NCT04617925Lead sponsorPhase 2Dec 31, 2020
NCT04564703Lead sponsorPhase 2Dec 31, 2020
NCT04483739Lead sponsorPhase 3Sep 25, 2020
NCT04483739CollaboratorPhase 3Sep 25, 2020
NCT04166565Lead sponsorPhase 2Oct 31, 2019

Details

Founded: Aalborg, DK Jan 1, 2005
Last known activity: Oct 31, 2025